CA2158173C - Method of treating addictive behaviors - Google Patents

Method of treating addictive behaviors Download PDF

Info

Publication number
CA2158173C
CA2158173C CA002158173A CA2158173A CA2158173C CA 2158173 C CA2158173 C CA 2158173C CA 002158173 A CA002158173 A CA 002158173A CA 2158173 A CA2158173 A CA 2158173A CA 2158173 C CA2158173 C CA 2158173C
Authority
CA
Canada
Prior art keywords
agonist
serotonin
dopamine
behavior
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002158173A
Other languages
English (en)
French (fr)
Other versions
CA2158173A1 (en
Inventor
Pietr Hitzig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2158173A1 publication Critical patent/CA2158173A1/en
Application granted granted Critical
Publication of CA2158173C publication Critical patent/CA2158173C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002158173A 1993-03-17 1994-03-17 Method of treating addictive behaviors Expired - Fee Related CA2158173C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3483493A 1993-03-17 1993-03-17
US08/034,834 1993-03-17
PCT/US1994/002875 WO1994021244A1 (en) 1993-03-17 1994-03-17 Method of treating addictive behaviors

Publications (2)

Publication Number Publication Date
CA2158173A1 CA2158173A1 (en) 1994-09-29
CA2158173C true CA2158173C (en) 2001-12-04

Family

ID=21878899

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002158173A Expired - Fee Related CA2158173C (en) 1993-03-17 1994-03-17 Method of treating addictive behaviors

Country Status (4)

Country Link
EP (1) EP0710106A4 (de)
AU (1) AU6410394A (de)
CA (1) CA2158173C (de)
WO (1) WO1994021244A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510540A (ja) * 1994-12-12 1998-10-13 オメロス メディカル システムズ，インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
US6413961B1 (en) 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
FR2760190B1 (fr) * 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
WO2009091605A2 (en) * 2008-01-17 2009-07-23 Health Innovations, Llc Taste titration therapies
CA2817071C (en) 2010-11-08 2018-04-24 Omeros Corporation Treatment of addiction and impulse-control disorders using pde7 inhibitors
US9220715B2 (en) 2010-11-08 2015-12-29 Omeros Corporation Treatment of addiction and impulse-control disorders using PDE7 inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255439A (en) * 1979-07-13 1981-03-10 Irving Cooper Means and method for aiding individuals to stop smoking

Also Published As

Publication number Publication date
AU6410394A (en) 1994-10-11
CA2158173A1 (en) 1994-09-29
WO1994021244A1 (en) 1994-09-29
EP0710106A1 (de) 1996-05-08
EP0710106A4 (de) 1999-07-21

Similar Documents

Publication Publication Date Title
US5776969A (en) Treatment of sleep disorders
US5502080A (en) Combined use of dopamine and serotonin agonists in the treatment of allergic disorders
AU733088B2 (en) Treatment of pain
US5658955A (en) Combined use of dopamine and serotonin agonists in the treatment of immune disorders
US5538992A (en) Potentiation of drug response
AU2006323048B2 (en) Compositions and methods for increasing insulin sensitivity
KR100236666B1 (ko) 트라마돌 및 코데인, 옥시코돈 또는 하이드로코돈을 함유하는 조성물 및 그의 용도
CA2163840A1 (en) Potentiation of drug response
JP2001503737A (ja) 糖尿病の発生を防止するためのシブトラミン類似体の利用
TWI325320B (en) Active ingredient combination for pharmacological addictive substance or intoxicant therapy
EP0759299B1 (de) Potenzierung von Serotonin-Wirkstoffresponz
WO2005065308A2 (en) Compositions and methods to treat recurrent medical conditions
EP0386117B1 (de) Behandlung des prämenstruellen oder späten lutealsphase-syndroms
US5958429A (en) Potentiation of serotonin response
CA2158173C (en) Method of treating addictive behaviors
EP0792649A1 (de) Behandlung von Schlafstörungen
Kennedy et al. Current perspectives on drug therapies for anorexia nervosa and bulimia nervosa
MX2008015887A (es) Tratamiento de condiciones psicologicas utilizando antagonista m1 de receptor muscarinico.
Roe From DOPA to Parkinson's disease: the early history of dopamine research
CN101472476B (zh) 毒蕈碱型受体m1拮抗剂在制备治疗肥胖症的药物中的应用
US6335372B1 (en) Treatment of obsessive compulsive disorder
CA2338326A1 (en) Use of moclobemide and metabolites for treating and preventing substance abuse
EP1667686A1 (de) Kombination vom serotonin wiederaufnahme hemmern und norepinephrin wiederaufnahme hemmern
WO2022003675A1 (en) Compositions and methods for treating psychiatric disorders or symptoms thereof
JP2007511577A (ja) （２ｓ，３ｓ）−２−（３−クロロフェニル）−３，５，５−トリメチル−２−モルホリノールの使用

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed